Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie | Synapse
March 18, 2008Open Access
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
FLO reduced toxicity as compared with FLP. In older adult patients, FLO also seemed to be associated with improved efficacy.